CollPlant Biotechnologies Statistics

Total Valuation

CLGN has a market cap or net worth of $19.24 million. The enterprise value is $11.35 million.

Market Cap	19.24M
Enterprise Value	11.35M

Important Dates

The last earnings date was Wednesday, May 28, 2025, before market open.

Earnings Date	May 28, 2025
Ex-Dividend Date	n/a

Share Statistics

CLGN has 11.45 million shares outstanding. The number of shares has increased by 0.17% in one year.

Current Share Class	11.45M
Shares Outstanding	11.45M
Shares Change (YoY)	+0.17%
Shares Change (QoQ)	-0.00%
Owned by Insiders (%)	32.27%
Owned by Institutions (%)	11.33%
Float	7.65M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	7.78
Forward PS	2.97
PB Ratio	1.55
P/TBV Ratio	1.57
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	4.59
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.48, with a Debt / Equity ratio of 0.23.

Current Ratio	4.48
Quick Ratio	4.14
Debt / Equity	0.23
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -75.27% and return on invested capital (ROIC) is -42.65%.

Return on Equity (ROE)	-75.27%
Return on Assets (ROA)	-38.34%
Return on Invested Capital (ROIC)	-42.65%
Return on Capital Employed (ROCE)	-100.43%
Revenue Per Employee	$43,368
Profits Per Employee	-$243,263
Employee Count	57
Asset Turnover	0.10
Inventory Turnover	1.92

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -67.69% in the last 52 weeks. The beta is 0.86, so CLGN's price volatility has been lower than the market average.

Beta (5Y)	0.86
52-Week Price Change	-67.69%
50-Day Moving Average	2.20
200-Day Moving Average	3.55
Relative Strength Index (RSI)	42.97
Average Volume (20 Days)	229,112

Short Selling Information

Short Interest	166,381
Short Previous Month	2,083
Short % of Shares Out	2.17%
Short % of Float	n/a
Short Ratio (days to cover)	1.09

Income Statement

In the last 12 months, CLGN had revenue of $2.47 million and -$13.87 million in losses. Loss per share was -$1.21.

Revenue	2.47M
Gross Profit	1.20M
Operating Income	-14.57M
Pretax Income	-7.50M
Net Income	-13.87M
EBITDA	-13.57M
EBIT	-14.57M
Loss Per Share	-$1.21

Full Income Statement

Balance Sheet

The company has $10.74 million in cash and $2.84 million in debt, giving a net cash position of $7.89 million or $0.69 per share.

Cash & Cash Equivalents	10.74M
Total Debt	2.84M
Net Cash	7.89M
Net Cash Per Share	$0.69
Equity (Book Value)	12.40M
Book Value Per Share	1.08
Working Capital	9.39M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$12.01 million and capital expenditures -$410,000, giving a free cash flow of -$12.42 million.

Operating Cash Flow	-12.01M
Capital Expenditures	-410,000
Free Cash Flow	-12.42M
FCF Per Share	-$1.08

Full Cash Flow Statement

Margins

Gross Margin	48.71%
Operating Margin	-589.40%
Pretax Margin	-560.92%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CLGN does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.17%
Shareholder Yield	-0.17%
Earnings Yield	-72.06%
FCF Yield	-64.53%

Analyst Forecast

The average price target for CLGN is $11.50, which is 584.52% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$11.50
Price Target Difference	584.52%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on November 21, 2016. It was a reverse split with a ratio of 0.6666666:1.

Last Split Date	Nov 21, 2016
Split Type	Reverse
Split Ratio	0.6666666:1

Scores

CLGN has an Altman Z-Score of -4.87 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-4.87
Piotroski F-Score	1